Cargando…

A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda

Evolutionary theory hypothesizes that intermediate virulence maximizes pathogen fitness as a result of a trade-off between virulence and transmission, but empirical evidence remains scarce. We bridge this gap using data from a large and long-standing HIV-1 prospective cohort, in Uganda. We use an ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanquart, François, Grabowski, Mary Kate, Herbeck, Joshua, Nalugoda, Fred, Serwadda, David, Eller, Michael A, Robb, Merlin L, Gray, Ronald, Kigozi, Godfrey, Laeyendecker, Oliver, Lythgoe, Katrina A, Nakigozi, Gertrude, Quinn, Thomas C, Reynolds, Steven J, Wawer, Maria J, Fraser, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115872/
https://www.ncbi.nlm.nih.gov/pubmed/27815945
http://dx.doi.org/10.7554/eLife.20492
_version_ 1782468588811059200
author Blanquart, François
Grabowski, Mary Kate
Herbeck, Joshua
Nalugoda, Fred
Serwadda, David
Eller, Michael A
Robb, Merlin L
Gray, Ronald
Kigozi, Godfrey
Laeyendecker, Oliver
Lythgoe, Katrina A
Nakigozi, Gertrude
Quinn, Thomas C
Reynolds, Steven J
Wawer, Maria J
Fraser, Christophe
author_facet Blanquart, François
Grabowski, Mary Kate
Herbeck, Joshua
Nalugoda, Fred
Serwadda, David
Eller, Michael A
Robb, Merlin L
Gray, Ronald
Kigozi, Godfrey
Laeyendecker, Oliver
Lythgoe, Katrina A
Nakigozi, Gertrude
Quinn, Thomas C
Reynolds, Steven J
Wawer, Maria J
Fraser, Christophe
author_sort Blanquart, François
collection PubMed
description Evolutionary theory hypothesizes that intermediate virulence maximizes pathogen fitness as a result of a trade-off between virulence and transmission, but empirical evidence remains scarce. We bridge this gap using data from a large and long-standing HIV-1 prospective cohort, in Uganda. We use an epidemiological-evolutionary model parameterised with this data to derive evolutionary predictions based on analysis and detailed individual-based simulations. We robustly predict stabilising selection towards a low level of virulence, and rapid attenuation of the virus. Accordingly, set-point viral load, the most common measure of virulence, has declined in the last 20 years. Our model also predicts that subtype A is slowly outcompeting subtype D, with both subtypes becoming less virulent, as observed in the data. Reduction of set-point viral loads should have resulted in a 20% reduction in incidence, and a three years extension of untreated asymptomatic infection, increasing opportunities for timely treatment of infected individuals. DOI: http://dx.doi.org/10.7554/eLife.20492.001
format Online
Article
Text
id pubmed-5115872
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-51158722016-11-28 A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda Blanquart, François Grabowski, Mary Kate Herbeck, Joshua Nalugoda, Fred Serwadda, David Eller, Michael A Robb, Merlin L Gray, Ronald Kigozi, Godfrey Laeyendecker, Oliver Lythgoe, Katrina A Nakigozi, Gertrude Quinn, Thomas C Reynolds, Steven J Wawer, Maria J Fraser, Christophe eLife Epidemiology and Global Health Evolutionary theory hypothesizes that intermediate virulence maximizes pathogen fitness as a result of a trade-off between virulence and transmission, but empirical evidence remains scarce. We bridge this gap using data from a large and long-standing HIV-1 prospective cohort, in Uganda. We use an epidemiological-evolutionary model parameterised with this data to derive evolutionary predictions based on analysis and detailed individual-based simulations. We robustly predict stabilising selection towards a low level of virulence, and rapid attenuation of the virus. Accordingly, set-point viral load, the most common measure of virulence, has declined in the last 20 years. Our model also predicts that subtype A is slowly outcompeting subtype D, with both subtypes becoming less virulent, as observed in the data. Reduction of set-point viral loads should have resulted in a 20% reduction in incidence, and a three years extension of untreated asymptomatic infection, increasing opportunities for timely treatment of infected individuals. DOI: http://dx.doi.org/10.7554/eLife.20492.001 eLife Sciences Publications, Ltd 2016-11-05 /pmc/articles/PMC5115872/ /pubmed/27815945 http://dx.doi.org/10.7554/eLife.20492 Text en © 2016, Blanquart et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Epidemiology and Global Health
Blanquart, François
Grabowski, Mary Kate
Herbeck, Joshua
Nalugoda, Fred
Serwadda, David
Eller, Michael A
Robb, Merlin L
Gray, Ronald
Kigozi, Godfrey
Laeyendecker, Oliver
Lythgoe, Katrina A
Nakigozi, Gertrude
Quinn, Thomas C
Reynolds, Steven J
Wawer, Maria J
Fraser, Christophe
A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda
title A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda
title_full A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda
title_fullStr A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda
title_full_unstemmed A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda
title_short A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda
title_sort transmission-virulence evolutionary trade-off explains attenuation of hiv-1 in uganda
topic Epidemiology and Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115872/
https://www.ncbi.nlm.nih.gov/pubmed/27815945
http://dx.doi.org/10.7554/eLife.20492
work_keys_str_mv AT blanquartfrancois atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT grabowskimarykate atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT herbeckjoshua atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT nalugodafred atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT serwaddadavid atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT ellermichaela atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT robbmerlinl atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT grayronald atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT kigozigodfrey atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT laeyendeckeroliver atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT lythgoekatrinaa atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT nakigozigertrude atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT quinnthomasc atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT reynoldsstevenj atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT wawermariaj atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT fraserchristophe atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT blanquartfrancois transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT grabowskimarykate transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT herbeckjoshua transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT nalugodafred transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT serwaddadavid transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT ellermichaela transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT robbmerlinl transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT grayronald transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT kigozigodfrey transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT laeyendeckeroliver transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT lythgoekatrinaa transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT nakigozigertrude transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT quinnthomasc transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT reynoldsstevenj transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT wawermariaj transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda
AT fraserchristophe transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda